Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosisHarrison, C N ; Vannucchi, A M ; Kiladjian, J-J ; Al-Ali, H K ; Gisslinger, H ; Knoops, L ; Cervantes, F ; Jones, M M ; Sun, K ; McQuitty, M ; Stalbovskaya, V ; Gopalakrishna, P ; Barbui, TLeukemia, 2016-08, Vol.30 (8), p.1701-1707 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
2 |
Material Type: Artigo
|
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patientsTefferi, A ; Guglielmelli, P ; Lasho, T L ; Rotunno, G ; Finke, C ; Mannarelli, C ; Belachew, A A ; Pancrazzi, A ; Wassie, E A ; Ketterling, R P ; Hanson, C A ; Pardanani, A ; Vannucchi, A MLeukemia, 2014-07, Vol.28 (7), p.1494-1500 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
3 |
Material Type: Artigo
|
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsGuglielmelli, P ; Lasho, T L ; Rotunno, G ; Score, J ; Mannarelli, C ; Pancrazzi, A ; Biamonte, F ; Pardanani, A ; Zoi, K ; Reiter, A ; Duncombe, A ; Fanelli, T ; Pietra, D ; Rumi, E ; Finke, C ; Gangat, N ; Ketterling, R P ; Knudson, R A ; Hanson, C A ; Bosi, A ; Pereira, A ; Manfredini, R ; Cervantes, F ; Barosi, G ; Cazzola, M ; Cross, N C P ; Vannucchi, A M ; Tefferi, ALeukemia, 2014-09, Vol.28 (9), p.1804-1810 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
4 |
Material Type: Artigo
|
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyTefferi, A ; Rumi, E ; Finazzi, G ; Gisslinger, H ; Vannucchi, A M ; Rodeghiero, F ; Randi, M L ; Vaidya, R ; Cazzola, M ; Rambaldi, A ; Gisslinger, B ; Pieri, L ; Ruggeri, M ; Bertozzi, I ; Sulai, N H ; Casetti, I ; Carobbio, A ; Jeryczynski, G ; Larson, D R ; Müllauer, L ; Pardanani, A ; Thiele, J ; Passamonti, F ; Barbui, TLeukemia, 2013-09, Vol.27 (9), p.1874-1881 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisTEFFERI, A ; LASHO, T. L ; MAI, M ; MCCLURE, R. F ; GILLILAND, D. G ; LEVINE, R. L ; PARDANANI, A ; VANNUCCHI, A. M ; ABDEL-WAHAB, O ; GUGLIELMELLI, P ; PATEL, J ; CARAMAZZA, D ; PIERI, L ; FINKE, C. M ; KILPIVAARA, O ; WADLEIGH, MLeukemia, 2010-07, Vol.24 (7), p.1302-1309 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
|
6 |
Material Type: Artigo
|
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaFINAZZI, G ; CAROBBIO, A ; ANTONIOLI, E ; GISSLINGER, H ; BUXHOFER-AUSCH, V ; GANGAT, N ; RAMBALDI, A ; TEFFERI, A ; BARBUI, T ; THIELE, J ; PASSAMONTI, F ; RUMI, E ; RUGGERI, M ; RODEGHIERO, F ; RANDI, M. L ; BERTOZZI, I ; VANNUCCHI, A. MLeukemia, 2012-04, Vol.26 (4), p.716-719 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
|
7 |
Material Type: Artigo
|
Mutations and prognosis in primary myelofibrosisVannucchi, A M ; Lasho, T L ; Guglielmelli, P ; Biamonte, F ; Pardanani, A ; Pereira, A ; Finke, C ; Score, J ; Gangat, N ; Mannarelli, C ; Ketterling, R P ; Rotunno, G ; Knudson, R A ; Susini, M C ; Laborde, R R ; Spolverini, A ; Pancrazzi, A ; Pieri, L ; Manfredini, R ; Tagliafico, E ; Zini, R ; Jones, A ; Zoi, K ; Reiter, A ; Duncombe, A ; Pietra, D ; Rumi, E ; Cervantes, F ; Barosi, G ; Cazzola, M ; Cross, N C P ; Tefferi, ALeukemia, 2013-09, Vol.27 (9), p.1861-1869 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
8 |
Material Type: Artigo
|
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosisPassamonti, F ; Giorgino, T ; Mora, B ; Guglielmelli, P ; Rumi, E ; Maffioli, M ; Rambaldi, A ; Caramella, M ; Komrokji, R ; Gotlib, J ; Kiladjian, J J ; Cervantes, F ; Devos, T ; Palandri, F ; De Stefano, V ; Ruggeri, M ; Silver, R T ; Benevolo, G ; Albano, F ; Caramazza, D ; Merli, M ; Pietra, D ; Casalone, R ; Rotunno, G ; Barbui, T ; Cazzola, M ; Vannucchi, A MLeukemia, 2017-12, Vol.31 (12), p.2726-2731 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
9 |
Material Type: Artigo
|
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisBarbui, T ; Thiele, J ; Vannucchi, A M ; Tefferi, ABlood cancer journal (New York), 2015-08, Vol.5 (8), p.e337-e337 [Periódico revisado por pares]United States: Springer Nature B.VTexto completo disponível |
|
10 |
Material Type: Artigo
|
Clinical implications of the JAK2 V617F mutation in essential thrombocythemiaAntonioli, E ; Guglielmelli, P ; Pancrazzi, A ; Bogani, C ; Verrucci, M ; Ponziani, V ; Longo, G ; Bosi, A ; Vannucchi, A MLeukemia, 2005-10, Vol.19 (10), p.1847-1849 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |